Envista Holdings Co. (NYSE:NVST) Receives $19.63 Consensus Price Target from Analysts

Envista Holdings Co. (NYSE:NVST) has earned an average recommendation of “Hold” from the fifteen research firms that are covering the company, MarketBeat reports. Three research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $19.63.

A number of research firms have weighed in on NVST. Robert W. Baird decreased their target price on shares of Envista from $19.00 to $17.00 and set a “neutral” rating on the stock in a research note on Monday, July 22nd. Wells Fargo & Company began coverage on Envista in a report on Tuesday, October 8th. They issued an “equal weight” rating and a $20.00 target price for the company. Stifel Nicolaus cut their price target on Envista from $20.00 to $18.00 and set a “buy” rating on the stock in a research note on Tuesday, July 30th. Needham & Company LLC reiterated a “hold” rating on shares of Envista in a report on Thursday, August 8th. Finally, Evercore ISI upped their price target on shares of Envista from $18.00 to $23.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd.

Envista Trading Up 3.3 %

Shares of Envista stock opened at $18.88 on Wednesday. The firm’s 50-day moving average price is $18.32 and its two-hundred day moving average price is $18.13. The company has a quick ratio of 1.90, a current ratio of 2.22 and a debt-to-equity ratio of 0.47. Envista has a 12-month low of $15.15 and a 12-month high of $25.64. The company has a market capitalization of $3.24 billion, a price-to-earnings ratio of -26.22 and a beta of 1.32.

Envista (NYSE:NVST) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.27 by ($0.16). The business had revenue of $633.10 million for the quarter, compared to the consensus estimate of $646.88 million. Envista had a positive return on equity of 4.86% and a negative net margin of 52.25%. Envista’s quarterly revenue was down 4.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.43 earnings per share. On average, analysts forecast that Envista will post 0.69 earnings per share for the current fiscal year.

Insider Activity

In other news, CFO Eric D. Hammes bought 24,532 shares of Envista stock in a transaction dated Monday, August 12th. The stock was bought at an average cost of $16.33 per share, for a total transaction of $400,607.56. Following the purchase, the chief financial officer now directly owns 24,532 shares in the company, valued at approximately $400,607.56. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.30% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Envista

Several large investors have recently added to or reduced their stakes in the business. GAMMA Investing LLC grew its position in Envista by 69.8% in the 3rd quarter. GAMMA Investing LLC now owns 1,766 shares of the company’s stock worth $35,000 after purchasing an additional 726 shares in the last quarter. Blue Trust Inc. lifted its holdings in Envista by 69.7% during the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock worth $39,000 after acquiring an additional 804 shares during the period. Versant Capital Management Inc boosted its position in Envista by 1,420.3% in the second quarter. Versant Capital Management Inc now owns 3,147 shares of the company’s stock worth $52,000 after purchasing an additional 2,940 shares during the last quarter. Innealta Capital LLC bought a new position in Envista in the 2nd quarter valued at $78,000. Finally, Summit Securities Group LLC purchased a new stake in shares of Envista during the 2nd quarter valued at $85,000.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.